Certification Rate
97.6%
High DOL cert
2026 data Public-data reference Official source
Takeda Pharmaceuticals USA, Inc.
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 169
- DOL-certified
- 97.6%
- Median offered wage
- $172,834
Lexington, MA NAICS: 325411
How many H-1B LCA filings list Takeda Pharmaceuticals USA, Inc.?
U.S. Department of Labor's OFLC discloses 169 Labor Condition Application filings naming Takeda Pharmaceuticals USA, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
How many H-1B petitions has USCIS approved for Takeda Pharmaceuticals USA, Inc.?
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 196 H-1B petitions naming Takeda Pharmaceuticals USA, Inc. through FY2024, and approved nearly every one of them: 99% approved (194 approvals, 2 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Takeda Pharmaceuticals USA, Inc. is listed in 169 DOL LCA filings, among the largest employer filers by filing volume in this extract. DOL certified 97.6% of those LCAs; the median listed offered wage is $172,834. This is not a USCIS approval, hiring, or sponsorship ranking.
- 169
- DOL LCA filings, FY2023–FY2026
- 97.6%
- DOL-certified
- $172,834
- median offered wage
- Top 1%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Lexington, MA.
Takeda Pharmaceuticals USA, Inc. LCA outcome mix
169DOL LCA filings on record
Saved on this device only, no account, no email.
Open saved list
Follow this profile's data updates
Updates when the published DOL data vintage changes; this is a feed, not an alert service.
Takeda Pharmaceuticals USA, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
169 1396th of 122824 higher than 121,428 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
LCA filing shape · Takeda Pharmaceuticals USA, Inc.
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $72,000–$370,800 .
Title concentration
- Director, Global Oncology Forecasting 4 · 2.4% · $244,300
- Associate Director, Omnichannel Engagement PDT 4 · 2.4% · $189,991
- Test Architect 3 · 1.8% · $161,829
- Service Governance Lead 3 · 1.8% · $201,678
- Quality Control Manager 3 · 1.8% · $140,994
Worksite counties
- CAMBRIDGE CITY, MA 28 · 41.2%
- LEXINGTON, MA 15 · 22.1%
- LAKE, IL 10 · 14.7%
- CHESTER, PA 8 · 11.8%
- WESTBOROUGH, MA 3 · 4.4%
DOL LCA release change
What changed between the two LCA fiscal years
- Takeda Pharmaceuticals USA, Inc.'s disclosed H-1B LCA filing count rose from 42 in FY2024 to 47 in FY2025 (+11.9%).
- Takeda Pharmaceuticals USA, Inc.'s average disclosed H-1B offered wage fell from $182,528 in FY2024 to $168,824 in FY2025 (-7.5%).
National-scale filing footprint
Takeda Pharmaceuticals USA, Inc. has filed 169 LCAs (more volume than 99% of U.S. employer filers in this extract). DOL certification: 97.6%. Worksites span 4 states , led by MA.
Above-prevailing wage posture
On 169 LCAs with comparable offered vs prevailing wages, Takeda Pharmaceuticals USA, Inc. averages about 27.2% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (58.6% of LCA filings).
Avg. Salary
$172,834
Well above portal avg
Total Workers
169
Moderate worker count
Compare with another employer filer
Takeda Pharmaceuticals USA, Inc. vs a peer vs the national average, from DOL LCA data.
Avg. offered wage$172,834 · 48% higher than Fidelity Technology Group, LLC
This filer
Peer
$116,535
National avg.
$113,357
Certification rate97.6% · 2% lower than Fidelity Technology Group, LLC
This filer
Peer
99.4%
National avg.
97.7%
Total LCA filings169 · 96% lower than Fidelity Technology Group, LLC
This filer
Peer
3,809
National avg.
17
FY2025 filings are 85% of FY2023
55 completed-year filings in FY2023, 47 in FY2025. The scale spans up to twice the earlier year's count: the midpoint is unchanged and the endpoint is at least doubled.
Wondering how long it takes USCIS to process an H-1B petition for this employer?
See current I-129 processing times →
Salary Analysis
Compensation range for H-1B positions at Takeda Pharmaceuticals USA, Inc.
Minimum
$72,000
Maximum
$370,800
Average Salary
$172,834
LCA Filing History
H-1B LCA filing trends from FY2023 to FY2026
FY2023 55 LCA filings · 96.4% DOL-certified · $158,611 avg
FY2024 42 LCA filings · 97.6% DOL-certified · $182,528 avg
FY2025 47 LCA filings · 97.9% DOL-certified · $168,824 avg
FY2026 is partial on this extract. Chart shows completed fiscal years only (through FY2025).
Top Occupations
Most frequently listed job titles at Takeda Pharmaceuticals USA, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Director, Global Oncology Forecasting | 4 | $244,300 |
| Associate Director, Omnichannel Engagement PDT | 4 | $189,991 |
| Test Architect | 3 | $161,829 |
| Service Governance Lead | 3 | $201,678 |
| Quality Control Manager | 3 | $140,994 |
| Product Manager | 3 | $183,054 |
| Data Platforms Engineer - GMSGQ | 3 | $127,409 |
| DDT Engineer Strategy & Business Excellence | 3 | $167,218 |
| USBU DD&T Data Products and Services Lead | 2 | $225,570 |
| Tech Lead-Biologics & Novel Modality Discv, Scie Informatics | 2 | $185,000 |
| Supplier Relationship Manager | 2 | $148,000 |
| Senior Validation Engineer | 2 | $105,000 |
| Senior Security Manager | 2 | $175,000 |
| Senior Manager, IBD Analytics | 2 | $162,552 |
| Senior Manager – Data Platform Lead – DAB | 2 | $175,000 |
Geographic Distribution
Where Takeda Pharmaceuticals USA, Inc. places H-1B workers across the United States
Nationwide peers near Takeda Pharmaceuticals USA, Inc.'s 169-LCA band
Cross-state DOL neighbors for Takeda Pharmaceuticals USA, Inc. - LCA filing-count and offered-wage axes, outside MA.
Similar LCA filing volume
Nearest cross-state employer filers by LCA filing count (169 here; floor ≥10 LCA filings).
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($172,834 here).
Disclaimer: Informational only, not professional advice.
Read with Takeda Pharmaceuticals USA, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MID-BOOK · CERT-CLEAN · WAGE-ELITE.
Agiletal Technologies Inc · MID-BOOK
ABS(total_petitions) peer at 169 LCAs (Δ 0 heavier vs Takeda Pharmaceuticals USA, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-ELITE.
Corteva Agriscience LLC · MID-BOOK
ABS(total_petitions) peer at 169 LCAs (Δ 0 heavier vs Takeda Pharmaceuticals USA, Inc.); CERT-CLEAN · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-ELITE.
Quantiphi, Inc. · MID-BOOK
ABS(total_petitions) peer at 169 LCAs (Δ 0 heavier vs Takeda Pharmaceuticals USA, Inc.); CERT-CLEAN · WAGE-PREMIUM vs this page's MID-BOOK · CERT-CLEAN · WAGE-ELITE.
RapidIT Inc · MID-BOOK
ABS(total_petitions) peer at 169 LCAs (Δ 0 heavier vs Takeda Pharmaceuticals USA, Inc.); CERT-SOLID · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-ELITE.
Fidelity Technology Group, LLC · LARGEST-distance pole
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Takeda Pharmaceuticals USA, Inc.'s MID-BOOK.
MA worksite board · MID-BOOK
Open the MA state board after the ABS peers. Takeda Pharmaceuticals USA, Inc. stamps MID-BOOK · CERT-CLEAN inside that worksite mix.
Salary calculator · WAGE-ELITE
Takeda Pharmaceuticals USA, Inc.'s WAGE-ELITE offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Takeda Pharmaceuticals USA, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- Takeda Pharmaceuticals USA, Inc. filed 169 LCAs in the indexed extract (97.6% certified in-file). That places it among the largest employer filers by volume in this extract.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in MA rank on LCA filing volume this vintage. MA filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.